DK0536197T3 - Ren, krystallinsk form af rifapentine - Google Patents
Ren, krystallinsk form af rifapentineInfo
- Publication number
- DK0536197T3 DK0536197T3 DK91911451.2T DK91911451T DK0536197T3 DK 0536197 T3 DK0536197 T3 DK 0536197T3 DK 91911451 T DK91911451 T DK 91911451T DK 0536197 T3 DK0536197 T3 DK 0536197T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline form
- rifapentine
- pure
- pure crystalline
- new pure
- Prior art date
Links
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 title abstract 2
- 229960002599 rifapentine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP90112458 | 1990-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0536197T3 true DK0536197T3 (da) | 1995-11-13 |
Family
ID=8204159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91911451.2T DK0536197T3 (da) | 1990-06-29 | 1991-06-05 | Ren, krystallinsk form af rifapentine |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0536197B1 (fr) |
| JP (1) | JP3350861B2 (fr) |
| KR (1) | KR0170000B1 (fr) |
| AT (1) | ATE125541T1 (fr) |
| BG (1) | BG60980B2 (fr) |
| CA (1) | CA2082809C (fr) |
| DE (1) | DE69111607T2 (fr) |
| DK (1) | DK0536197T3 (fr) |
| ES (1) | ES2075454T3 (fr) |
| HU (1) | HU211168A9 (fr) |
| IE (1) | IE68687B1 (fr) |
| WO (1) | WO1992000302A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE50212753D1 (de) | 2001-07-26 | 2008-10-23 | Alstom Technology Ltd | Vormischbrenner mit hoher Flammenstabilität |
| ITMI20032144A1 (it) * | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| US7262236B2 (en) | 2004-04-26 | 2007-08-28 | Milliken & Company | Acetal-based compositions |
| PT1698630E (pt) * | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais |
| EP2401282B2 (fr) | 2009-12-28 | 2017-01-04 | Silvio Massimo Lavagna | Procédés pour la production de rifaximine amorphe |
| IT1397107B1 (it) * | 2009-12-28 | 2012-12-28 | Lavagna | Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo. |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| CN102079749B (zh) * | 2010-11-25 | 2012-07-04 | 河北欣港药业有限公司 | 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法 |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| CN103772413B (zh) * | 2014-02-07 | 2016-01-20 | 天津大学 | 一种利福平ⅱ晶型的制备方法 |
| US20240199642A1 (en) * | 2021-04-21 | 2024-06-20 | Interquim S.A. De C.V. | Method for obtaining rifapentine with a new crystalline form |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1478563A (en) * | 1975-03-05 | 1977-07-06 | Lepetit Spa | Rifamycin derivatives |
| GB8816620D0 (en) * | 1988-07-13 | 1988-08-17 | Lepetit Spa | Rifapentine hydrohalides |
-
1991
- 1991-06-05 DE DE69111607T patent/DE69111607T2/de not_active Expired - Lifetime
- 1991-06-05 ES ES91911451T patent/ES2075454T3/es not_active Expired - Lifetime
- 1991-06-05 DK DK91911451.2T patent/DK0536197T3/da active
- 1991-06-05 AT AT91911451T patent/ATE125541T1/de not_active IP Right Cessation
- 1991-06-05 EP EP91911451A patent/EP0536197B1/fr not_active Expired - Lifetime
- 1991-06-05 CA CA002082809A patent/CA2082809C/fr not_active Expired - Lifetime
- 1991-06-05 JP JP51003691A patent/JP3350861B2/ja not_active Expired - Lifetime
- 1991-06-05 KR KR1019920703373A patent/KR0170000B1/ko not_active Expired - Lifetime
- 1991-06-05 WO PCT/EP1991/001036 patent/WO1992000302A1/fr not_active Ceased
- 1991-06-28 IE IE226691A patent/IE68687B1/en not_active IP Right Cessation
-
1994
- 1994-02-24 BG BG098539A patent/BG60980B2/bg unknown
-
1995
- 1995-06-21 HU HU95P/P00307P patent/HU211168A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2082809C (fr) | 1995-10-17 |
| KR0170000B1 (ko) | 1999-02-01 |
| HU211168A9 (en) | 1995-11-28 |
| JPH05507690A (ja) | 1993-11-04 |
| DE69111607D1 (de) | 1995-08-31 |
| WO1992000302A1 (fr) | 1992-01-09 |
| IE68687B1 (en) | 1996-07-10 |
| HK1005454A1 (en) | 1999-01-08 |
| JP3350861B2 (ja) | 2002-11-25 |
| BG60980B2 (bg) | 1996-07-31 |
| IE912266A1 (en) | 1992-01-01 |
| EP0536197B1 (fr) | 1995-07-26 |
| DE69111607T2 (de) | 1995-12-21 |
| ES2075454T3 (es) | 1995-10-01 |
| EP0536197A1 (fr) | 1993-04-14 |
| KR930701448A (ko) | 1993-06-11 |
| ATE125541T1 (de) | 1995-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| MA22842A1 (fr) | Procede de preparation de compositions de vaccin. | |
| FI931708A0 (fi) | Herbicida substituerade aryl-haloalkylpyrazoler | |
| FI931031A0 (fi) | Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar | |
| DK0629608T3 (da) | Fremgangsmåde til fremstilling af N-acyl-N,N',N'-ethylendiamintrieddikesyrederivater | |
| SE8300736D0 (sv) | Novel pharmacologically active compounds | |
| ES2128519T3 (es) | Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| GB8823567D0 (en) | 4h-1-benzopyran-4-one derivative/its salt & process for producing same | |
| DK0490649T3 (da) | En fysisk form af N- 4- 5-(cyklopentyloxycarbonylamino)-1-methylindol-3-ylmethyl -3-methoxybenzoyl -2-methylbenzensulfonamid, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende den | |
| DK0458699T3 (da) | Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris | |
| RU93004445A (ru) | Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты | |
| DK0536197T3 (da) | Ren, krystallinsk form af rifapentine | |
| ES8609312A1 (es) | Procedimiento para la preparacion de silibinina exenta de isosilibina | |
| DK0750616T3 (da) | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser | |
| ITRM910430A1 (it) | Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego | |
| DK0487319T3 (da) | Hidtil ukendt heptamethylindanforbindelse | |
| DK0499157T3 (da) | Fremgangsmåde til fremstilling af 1,3-dioxoler | |
| DK0625153T3 (da) | Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf | |
| MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. | |
| ES2104295T3 (es) | Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| FI903701A0 (fi) | Reninhaemmande amino-oligohydroxiderivat. | |
| SE9203824D0 (sv) | Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same | |
| FI870994A0 (fi) | Foerfarande foer framstaellning av stabila, injekterbara farmaceutiska kompositioner, vilka innehaoller 1,4-dihydroxi-5,8-bis/2-(2-hydroxietylamino)etylamino/ antrakinondihydroklorid. | |
| DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
| DK0427160T3 (da) | Benzylselenobenzamid af aminopyridiner og picolylaminer |